Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Wraps Up Share Conversion With Amplimedical

NEW YORK (GenomeWeb News) - Nanogen on June 30 issued 2.9 million shares of its common stock to Amplimedical upon conversion of a promissory note issued to that company, whose diagnostics division Nanogen acquired in the spring, according to documents filed with the Securities and Exchange Commission today.
Amplimedical received the convertible promissory note, dated May 1, when Nanogen acquired the company on April 19. The €6.1 million note ($7.5 million) was convertible into Nanogen common shares, the company said at the time.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.